Clinical Trial Update: A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind, dose-escalation study in postoperative pain after open inguinal herniorrhaphy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inguinal Herniorrhaphy

Snippet

Sponsor: Cali Pharmaceuticals LLC | Conditions: Inguinal Herniorrhaphy | Phase 2 | Status: COMPLETED